CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
71 hedge funds and large institutions have $1.42B invested in China Biologic Products Holdings, Inc. in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
32% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 25
Holders
71
Holding in Top 10
6
Calls
$25M
Puts
$14.8M
Top Buyers
| 1 | +$139M | |
| 2 | +$13.1M | |
| 3 | +$8.75M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.48M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$5.26M |
Top Sellers
| 1 | -$31.2M | |
| 2 | -$26M | |
| 3 | -$11.2M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$9.9M |
| 5 |
Goldman Sachs
New York
|
-$7.66M |